Share this article
Gettyimages A

Autoimmune Association Most Favored Nation Model (MFN) Statement of Concern

Gettyimages A X

The Autoimmune Association is greatly concerned that the Most Favored Nation Model (MFN) Interim Final Rule released by the Centers for Medicare and Medicaid (CMS) on November 20th and set to take effect later this month will limit access and threaten innovation to critical medicines for our nation’s most vulnerable patients. As proposed, the MFN Model would be mandatory, last for seven years, and initially affect 50 drugs reimbursed under Medicare Part B. Much like the International Pricing Index (IPI) and other structures floated previously, the MFN would adopt prices set by a group of foreign countries that have very different, often discriminatory models for health care that often deny or delay coverage for medicines currently available to Americans with autoimmune diseases. Autoimmune Association understands that these reference nations employ Quality Adjusted Life Years (QALYs) in their calculations for health care coverage, value and cost which is highly discriminatory towards people with chronic conditions and disabilities.

Autoimmune Association supports efforts to improve access and reduce costs for autoimmune patients and all Americans. But MFN implementation without the opportunity for full public comment and appropriate consideration of potential negative consequences on access to current and future life-changing therapies for Medicare Part B patients and others puts these groups at risk for managing their health. Autoimmune Association urges the Administration to immediately withdraw the MFN Model interim Final Rule to avoid importing a pricing structure that is incompatible with the American health care system, patient needs, and national values. From a patient perspective, the MFN Model is not an equitable, effective, nor viable approach for truly promoting health and well-being for those with autoimmune and other chronic conditions and disabilities. Thus, Autoimmune Association encourages alternative, U.S.-based strategies for achieving savings in health care spending.

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

Make a Difference During Autoimmune Awareness Month

Autoimmune Awareness Month – observed every March – aims to increase understanding and awareness of autoimmune diseases. Autoimmune diseases are a group of...
Autoimmune Association Image Do Not Touch

New Scorecard Highlights Access Barriers Faced by People Living with Autoimmune Diseases

Let My Doctors Decide – an initiative of the Autoimmune Association to raise awareness of insurer access restrictions – has rolled out a...
Autoimmune Association Image Do Not Touch

How Can We Curb the Autoimmune Epidemic? New Paper Suggests a Path Forward

Both autoimmunity and autoimmune diseases are dramatically increasing in many parts of the world, notes Dr. Frederick Miller, a current NIH Scientist Emeritus...
Autoimmune Association Image Do Not Touch

President Biden Signs Legislation that Includes Language to Establish an Office of Autoimmune Disease Research

December 29, 2022 — The Autoimmune Association applauds Congress for passing and President Biden for signing the omnibus federal spending bill that includes...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.